AG˹ٷ

STOCK TITAN

[Form 4] Immunome, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Globe Life Inc. (GL) Form 4 � insider activity dated 30-31 Jul 2025: Co-Chairman & CEO Frank M. Svoboda exercised two tranches of employee stock options, purchasing 25,000 common shares at an $82.56 strike (total cost � $2.06 m). He immediately sold the same 25,000 shares on the open market in four blocks at blended prices of $141.15-$142.58, generating � $3.54 m gross proceeds.

Net effect: direct ownership ended unchanged at 32,747 shares; indirect holdings remain 134,898 shares (family trust) and 1,939.6 units (401-k). Option inventory declined from 50,000 to 25,000 unexercised options with the 2/28/2026 expiry.

Take-aways for investors: the transactions appear cash-neutral on share count but realise a ~$1.5 m spread for the executive. Although the sales represent a modest fraction of his total economic exposure, they may be interpreted as short-term profit-taking rather than a change in long-term commitment.

Globe Life Inc. (GL) Form 4 � attività insider datata 30-31 lug 2025: Il Co-Presidente e CEO Frank M. Svoboda ha esercitato due tranche di opzioni azionarie per dipendenti, acquistando 25.000 azioni ordinarie a un prezzo di esercizio di 82,56$ (costo totale � 2,06 milioni di dollari). Ha immediatamente venduto le stesse 25.000 azioni sul mercato aperto in quattro blocchi a prezzi medi compresi tra 141,15$ e 142,58$, generando circa 3,54 milioni di dollari di proventi lordi.

Effetto netto: la proprietà diretta è rimasta invariata a 32.747 azioni; le partecipazioni indirette restano 134.898 azioni (trust familiare) e 1.939,6 unità (401-k). L'inventario di opzioni è diminuito da 50.000 a 25.000 opzioni non esercitate con scadenza il 28/02/2026.

Considerazioni per gli investitori: le transazioni risultano neutre in termini di numero di azioni ma realizzano un guadagno di circa 1,5 milioni di dollari per il dirigente. Sebbene le vendite rappresentino una frazione modesta della sua esposizione economica totale, possono essere interpretate come una presa di profitto a breve termine piuttosto che un cambiamento nell'impegno a lungo termine.

Globe Life Inc. (GL) Formulario 4 � actividad de insiders fechada 30-31 de julio de 2025: El Co-Presidente y CEO Frank M. Svoboda ejerció dos tramos de opciones sobre acciones para empleados, comprando 25,000 acciones comunes a un precio de ejercicio de $82.56 (costo total � $2.06 millones). Inmediatamente vendió las mismas 25,000 acciones en el mercado abierto en cuatro bloques a precios promedio de $141.15-$142.58, generando aproximadamente $3.54 millones en ingresos brutos.

Efecto neto: la propiedad directa quedó sin cambios en 32,747 acciones; las participaciones indirectas permanecen en 134,898 acciones (fideicomiso familiar) y 1,939.6 unidades (401-k). El inventario de opciones disminuyó de 50,000 a 25,000 opciones no ejercidas con vencimiento el 28/02/2026.

Conclusiones para los inversores: las transacciones parecen neutrales en cuanto al número de acciones, pero generan una ganancia de aproximadamente $1.5 millones para el ejecutivo. Aunque las ventas representan una fracción modesta de su exposición económica total, pueden interpretarse como una toma de ganancias a corto plazo en lugar de un cambio en el compromiso a largo plazo.

Globe Life Inc. (GL) Form 4 � 내부� 거래 활동, 2025� 7� 30-31일자: 공동 회장 � CEO Frank M. Svoboda� � 차례� 걸쳐 직원 스톡옵션� 행사하여 행사가� $82.56� 25,000 보통주를 매입했습니다(� 비용 � 206� 달러). 그는 즉시 같은 25,000주를 � 번에 나누� 공개 시장에서 $141.15-$142.58� 평균 가격으� 매도하여 � 354� 달러� � 수익� 올렸습니�.

순효�: 직접 보유 주식은 32,747�� 변� 없었으며, 간접 보유� 134,898�(가� 신탁)와 1,939.6 단위(401-k)� 유지되었습니�. 옵션 잔고� 50,000주에� 만기� 2026� 2� 28일까지 25,000 미행� 옵션으로 줄었습니�.

투자자를 위한 시사�: 이번 거래� 주식 � 기준으로� 현금 중립적이지� 경영진에� � 150� 달러� 차익� 실현시켰습니�. 매도 물량은 전체 경제� 노출� 일부� 불과하지�, 장기� 헌신 변화보다는 단기 차익 실현으로 해석� � 있습니다.

Globe Life Inc. (GL) Formulaire 4 � activité d’initiés datée du 30-31 juillet 2025 : Le co-président et PDG Frank M. Svoboda a exercé deux tranches d’options d’achat d’actions pour employés, achetant 25 000 actions ordinaires à un prix d’exercice de 82,56 $ (coût total � 2,06 M$). Il a immédiatement vendu ces mêmes 25 000 actions sur le marché ouvert en quatre blocs à des prix moyens compris entre 141,15 $ et 142,58 $, générant environ 3,54 M$ de produit brut.

Effet net : la propriété directe est restée inchangée à 32 747 actions ; les participations indirectes demeurent à 134 898 actions (fiducie familiale) et 1 939,6 unités (401-k). L’inventaire d’options a diminué de 50 000 à 25 000 options non exercées avec une échéance au 28/02/2026.

Points clés pour les investisseurs : les transactions semblent neutres en termes de nombre d’actions mais réalisent un écart d’environ 1,5 M$ pour le dirigeant. Bien que les ventes représentent une fraction modeste de son exposition économique totale, elles peuvent être interprétées comme une prise de bénéfices à court terme plutôt qu’un changement d’engagement à long terme.

Globe Life Inc. (GL) Form 4 � Insider-Aktivität vom 30.-31. Juli 2025: Co-Vorsitzender und CEO Frank M. Svoboda übte zwei Tranchen von Mitarbeiteraktienoptionen aus und erwarb 25.000 Stammaktien zu einem Ausübungspreis von 82,56 $ (Gesamtkosten � 2,06 Mio. $). Er verkaufte die gleichen 25.000 Aktien sofort in vier Tranchen am offenen Markt zu durchschnittlichen Preisen von 141,15 $ bis 142,58 $ und erzielte so Bruttoerlöse von ca. 3,54 Mio. $.

Nettoeffekt: Das direkte Eigentum blieb unverändert bei 32.747 Aktien; indirekte Beteiligungen bleiben bei 134.898 Aktien (Familientrust) und 1.939,6 Einheiten (401-k). Das Optionsinventar verringerte sich von 50.000 auf 25.000 nicht ausgeübte Optionen mit Ablaufdatum 28.02.2026.

Fazit für Investoren: Die Transaktionen sind in Bezug auf die Aktienanzahl cashneutral, realisieren jedoch eine Spanne von ca. 1,5 Mio. $ für den Geschäftsführer. Obwohl die Verkäufe einen bescheidenen Anteil seiner gesamten wirtschaftlichen Beteiligung darstellen, können sie eher als kurzfristige Gewinnmitnahme denn als Änderung des langfristigen Engagements interpretiert werden.

Positive
  • None.
Negative
  • 25,000 shares sold by CEO (~$3.5 m) could be read as insider selling pressure, though offset by equal option exercise.

Insights

TL;DR: CEO exercised options, sold equal shares, ownership flat; signals liquidity move, not strategy shift.

The matched exercise-and-sell pattern suggests routine monetisation of previously granted options. The $82.56 strike versus $141+ market price crystallises a ~72% gain, consistent with typical executive diversification. Net holdings unchanged at 32.7k direct shares plus sizable indirect stakes indicates continued alignment with shareholders. Transaction size (~$3.5 m) is immaterial relative to GL’s ~$10 bn market cap, so price impact should be negligible. Sentiment lean: mildly negative simply because sales outnumber buys on tape.

TL;DR: Routine Rule 10b5-1-style trades; no governance red flags.

The filing shows no 10b-5-1 checkbox marked, yet timing near option expiry is typical. Svoboda retains >170k aggregate shares (direct+indirect), preserving meaningful skin in the game. No patterns of accelerating disposals are evident. From a governance lens, the activity is neutral; investors should monitor subsequent filings for trend confirmation.

Globe Life Inc. (GL) Form 4 � attività insider datata 30-31 lug 2025: Il Co-Presidente e CEO Frank M. Svoboda ha esercitato due tranche di opzioni azionarie per dipendenti, acquistando 25.000 azioni ordinarie a un prezzo di esercizio di 82,56$ (costo totale � 2,06 milioni di dollari). Ha immediatamente venduto le stesse 25.000 azioni sul mercato aperto in quattro blocchi a prezzi medi compresi tra 141,15$ e 142,58$, generando circa 3,54 milioni di dollari di proventi lordi.

Effetto netto: la proprietà diretta è rimasta invariata a 32.747 azioni; le partecipazioni indirette restano 134.898 azioni (trust familiare) e 1.939,6 unità (401-k). L'inventario di opzioni è diminuito da 50.000 a 25.000 opzioni non esercitate con scadenza il 28/02/2026.

Considerazioni per gli investitori: le transazioni risultano neutre in termini di numero di azioni ma realizzano un guadagno di circa 1,5 milioni di dollari per il dirigente. Sebbene le vendite rappresentino una frazione modesta della sua esposizione economica totale, possono essere interpretate come una presa di profitto a breve termine piuttosto che un cambiamento nell'impegno a lungo termine.

Globe Life Inc. (GL) Formulario 4 � actividad de insiders fechada 30-31 de julio de 2025: El Co-Presidente y CEO Frank M. Svoboda ejerció dos tramos de opciones sobre acciones para empleados, comprando 25,000 acciones comunes a un precio de ejercicio de $82.56 (costo total � $2.06 millones). Inmediatamente vendió las mismas 25,000 acciones en el mercado abierto en cuatro bloques a precios promedio de $141.15-$142.58, generando aproximadamente $3.54 millones en ingresos brutos.

Efecto neto: la propiedad directa quedó sin cambios en 32,747 acciones; las participaciones indirectas permanecen en 134,898 acciones (fideicomiso familiar) y 1,939.6 unidades (401-k). El inventario de opciones disminuyó de 50,000 a 25,000 opciones no ejercidas con vencimiento el 28/02/2026.

Conclusiones para los inversores: las transacciones parecen neutrales en cuanto al número de acciones, pero generan una ganancia de aproximadamente $1.5 millones para el ejecutivo. Aunque las ventas representan una fracción modesta de su exposición económica total, pueden interpretarse como una toma de ganancias a corto plazo en lugar de un cambio en el compromiso a largo plazo.

Globe Life Inc. (GL) Form 4 � 내부� 거래 활동, 2025� 7� 30-31일자: 공동 회장 � CEO Frank M. Svoboda� � 차례� 걸쳐 직원 스톡옵션� 행사하여 행사가� $82.56� 25,000 보통주를 매입했습니다(� 비용 � 206� 달러). 그는 즉시 같은 25,000주를 � 번에 나누� 공개 시장에서 $141.15-$142.58� 평균 가격으� 매도하여 � 354� 달러� � 수익� 올렸습니�.

순효�: 직접 보유 주식은 32,747�� 변� 없었으며, 간접 보유� 134,898�(가� 신탁)와 1,939.6 단위(401-k)� 유지되었습니�. 옵션 잔고� 50,000주에� 만기� 2026� 2� 28일까지 25,000 미행� 옵션으로 줄었습니�.

투자자를 위한 시사�: 이번 거래� 주식 � 기준으로� 현금 중립적이지� 경영진에� � 150� 달러� 차익� 실현시켰습니�. 매도 물량은 전체 경제� 노출� 일부� 불과하지�, 장기� 헌신 변화보다는 단기 차익 실현으로 해석� � 있습니다.

Globe Life Inc. (GL) Formulaire 4 � activité d’initiés datée du 30-31 juillet 2025 : Le co-président et PDG Frank M. Svoboda a exercé deux tranches d’options d’achat d’actions pour employés, achetant 25 000 actions ordinaires à un prix d’exercice de 82,56 $ (coût total � 2,06 M$). Il a immédiatement vendu ces mêmes 25 000 actions sur le marché ouvert en quatre blocs à des prix moyens compris entre 141,15 $ et 142,58 $, générant environ 3,54 M$ de produit brut.

Effet net : la propriété directe est restée inchangée à 32 747 actions ; les participations indirectes demeurent à 134 898 actions (fiducie familiale) et 1 939,6 unités (401-k). L’inventaire d’options a diminué de 50 000 à 25 000 options non exercées avec une échéance au 28/02/2026.

Points clés pour les investisseurs : les transactions semblent neutres en termes de nombre d’actions mais réalisent un écart d’environ 1,5 M$ pour le dirigeant. Bien que les ventes représentent une fraction modeste de son exposition économique totale, elles peuvent être interprétées comme une prise de bénéfices à court terme plutôt qu’un changement d’engagement à long terme.

Globe Life Inc. (GL) Form 4 � Insider-Aktivität vom 30.-31. Juli 2025: Co-Vorsitzender und CEO Frank M. Svoboda übte zwei Tranchen von Mitarbeiteraktienoptionen aus und erwarb 25.000 Stammaktien zu einem Ausübungspreis von 82,56 $ (Gesamtkosten � 2,06 Mio. $). Er verkaufte die gleichen 25.000 Aktien sofort in vier Tranchen am offenen Markt zu durchschnittlichen Preisen von 141,15 $ bis 142,58 $ und erzielte so Bruttoerlöse von ca. 3,54 Mio. $.

Nettoeffekt: Das direkte Eigentum blieb unverändert bei 32.747 Aktien; indirekte Beteiligungen bleiben bei 134.898 Aktien (Familientrust) und 1.939,6 Einheiten (401-k). Das Optionsinventar verringerte sich von 50.000 auf 25.000 nicht ausgeübte Optionen mit Ablaufdatum 28.02.2026.

Fazit für Investoren: Die Transaktionen sind in Bezug auf die Aktienanzahl cashneutral, realisieren jedoch eine Spanne von ca. 1,5 Mio. $ für den Geschäftsführer. Obwohl die Verkäufe einen bescheidenen Anteil seiner gesamten wirtschaftlichen Beteiligung darstellen, können sie eher als kurzfristige Gewinnmitnahme denn als Änderung des langfristigen Engagements interpretiert werden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rosett Max

(Last) (First) (Middle)
C/O IMMUNOME, INC.
18702 N. CREEK PARKWAY, SUITE 100

(Street)
BOTHELL WA 98011

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Immunome Inc. [ IMNM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $10.6 07/29/2025 A 207,000 (1) 07/28/2035 Common Stock 207,000 $0 207,000 D
Explanation of Responses:
1. 25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
/s/ Sandra Stoneman, Attorney-in-Fact 07/31/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Globe Life (GL) shares did CEO Frank Svoboda sell?

He sold a total of 25,000 common shares on 30-31 Jul 2025.

What price did the insider receive for the Globe Life shares?

Weighted average sale prices ranged from $141.02 to $142.58 per share.

Did the CEO's overall share ownership in GL decrease?

No. After exercising and selling equal amounts, his direct stake remained 32,747 shares, plus indirect holdings.

How many unexercised options remain after the transactions?

Svoboda still holds 25,000 employee stock options expiring 28 Feb 2026.

Is this Form 4 activity considered material to Globe Life's valuation?

Given the small size versus GL’s market cap, analysts generally view the activity as not materially impactful.
Immunome Inc

NASDAQ:IMNM

IMNM Rankings

IMNM Latest News

IMNM Latest SEC Filings

IMNM Stock Data

935.38M
77.01M
19.27%
62.86%
10.99%
Biotechnology
Pharmaceutical Preparations
United States
BOTHELL